Samsung BioLogics

Showing 6 posts of 6 posts found.


Samsung Biologics names John Rim as CEO and President

December 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …


AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal

September 22, 2020
Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma

AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …


Samsung BioLogics delisted over accounting violations

November 14, 2018
Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …


Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …


Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

October 30, 2017
Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …


Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug

July 4, 2017
Manufacturing and Production Samsung BioLogics, Sun Pharma

India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …

Latest content